Artwork

Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Meet the mAbs: the new treatments for vulnerable patients with COVID-19

23:25
 
Jaa
 

Manage episode 323237391 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
There have been some promising trial results recently regarding the efficacy of monoclonal antibodies (or mAbs) in patients with COVID-19. In this podcast, features editor Dawn Connelly and clinical and science editor Julia Robinson investigate the science behind these exciting new treatments and the potential role of pharmacists in preparing, supplying and assessing patients for their use. Robinson also visits the aseptics lab at King's College Hospital in London to find out from senior pharmacist James Cheung how mAbs are made. With thanks to associate professor Al Edwards from the Reading School of Pharmacy and PJ deputy news editor Carolyn Wickware for their help in preparing this podcast. This episode was produced by Geoff Marsh. Our exclusive on NHS plans for a community-based mAbs service: https://tinyurl.com/mabsservice Here is a link to more information on the clinical trials discussed in this podcast: tinyurl.com/COVIDtxs
  continue reading

48 jaksoa

Artwork
iconJaa
 
Manage episode 323237391 series 3329558
Sisällön tarjoaa The PJ Pod and Pharmaceutical Journal. The PJ Pod and Pharmaceutical Journal tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
There have been some promising trial results recently regarding the efficacy of monoclonal antibodies (or mAbs) in patients with COVID-19. In this podcast, features editor Dawn Connelly and clinical and science editor Julia Robinson investigate the science behind these exciting new treatments and the potential role of pharmacists in preparing, supplying and assessing patients for their use. Robinson also visits the aseptics lab at King's College Hospital in London to find out from senior pharmacist James Cheung how mAbs are made. With thanks to associate professor Al Edwards from the Reading School of Pharmacy and PJ deputy news editor Carolyn Wickware for their help in preparing this podcast. This episode was produced by Geoff Marsh. Our exclusive on NHS plans for a community-based mAbs service: https://tinyurl.com/mabsservice Here is a link to more information on the clinical trials discussed in this podcast: tinyurl.com/COVIDtxs
  continue reading

48 jaksoa

Todos os episódios

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas